Trending

Strategic Partnership: Torrent Pharma & Zydus Collaborate On Liver Disease Drug

In a strategic move, Torrent Pharmaceuticals has announced a significant licensing agreement with Zydus Lifesciences to co-market a groundbreaking medication for the treatment of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). The collaborative effort aims to make...